Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-12

Clinical Trial Update: Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens [Phase 2]

View source ↗

Summary

A Phase 2 trial completed evaluating different regimens of levodopa/carbidopa/entacapone for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stalevo (levodopa;carbidopa;entacapone)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED